CRTO(CRTO)
CRTO
$17.41—
NASDAQ
$17.41—
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $1.05B | $1.08B | $1.15B |
| Low | $1.04B | $1.02B | $971M |
| High | $1.17B | $1.17B | $1.42B |
| EBITDA Avg | $416M | $443M | $393M |
| Low | $405M | $428M | $340M |
| High | $426M | $458M | $575M |
| EBIT Avg | $304M | $345M | $305M |
| Low | $294M | $330M | $252M |
| High | $315M | $360M | $487M |
| Net Income Avg | $195M | $221M | $196M |
| Low | $188M | $212M | $161M |
| High | $202M | $231M | $313M |
| EPS Avg | $3.65 | $4.16 | $4.59 |
| Low | $3.54 | $3.99 | $3.04 |
| High | $3.81 | $4.35 | $5.89 |
| Analysts (Rev / EPS) | 6 / 5 | 8 / 6 | 8 / 5 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $239M | $300M | $243M | $256M | $243M | $306M |
| Low | $239M | $277M | $233M | $246M | $234M | $294M |
| High | $240M | $337M | $255M | $270M | $256M | $322M |
| EBITDA Avg | $73M | $140M | $89M | $93M | $88M | $138M |
| Low | $68M | $138M | $86M | $89M | $85M | $132M |
| High | $75M | $141M | $94M | $97M | $93M | $146M |
| EBIT Avg | $46M | $114M | $64M | $68M | $65M | $115M |
| Low | $41M | $112M | $61M | $65M | $61M | $109M |
| High | $48M | $115M | $68M | $73M | $69M | $123M |
| Net Income Avg | $29M | $73M | $41M | $44M | $41M | $74M |
| Low | $26M | $72M | $39M | $41M | $39M | $70M |
| High | $31M | $74M | $44M | $47M | $44M | $79M |
| EPS Avg | $0.58 | $1.45 | $0.81 | $0.86 | $0.82 | $1.46 |
| Low | $0.52 | $1.43 | $0.77 | $0.82 | $0.77 | $1.39 |
| High | $0.61 | $1.46 | $0.87 | $0.92 | $0.87 | $1.56 |
| Analysts (Rev / EPS) | 4 / 5 | 5 / 4 | 4 / 1 | 4 / 1 | 4 / 1 | 4 / 1 |